Table 1.
Anthropometric and metabolic characterization of the cohort.
| BMI <30 kg/m2 (n = 16) | BMI 30–40 kg/m2 (n = 51) | BMI >40 kg/m2 (n = 458) | |
|---|---|---|---|
| Age (years) | 65.09 ± 13.06 | 48.31 ± 11.66 | 47.02 ± 11.86 |
| Men/Women (n) | 12/4 | 12/39 | 119/339 |
| T2D (n) | 3 | 20 | 182 |
| Body weight (kg) | 78.88 ± 10.84 | 109.23 ± 12.67 | 143.29 ± 26.78 |
| Height (m) | 1.76 ± 0.09 | 1.70 ± 0.07 | 1.69 ± 0.09 |
| BMI (kg/m2) | 25.43 ± 2.31 | 37.51 ± 2.57 | 50.01 ± 7.30 |
| Body fat (%) | 22.88 ± 2.88 | 44.05 ± 9.76 | 49.59 ± 9.84 |
| Waist circumference (cm) | 95.17 ± 11.82 | 122.50 ± 9.19 | 145.56 ± 160.3 |
| Hip circumference (cm) | 98.33 ± 8.37 | 124.00 ± 11.31 | 148.06 ± 14.03 |
| WHR | 0.97 ± 0.09 | 0.99 ± 0.17 | 0.99 ± 0.10 |
| FPG (mmol/l) | 5.73 ± 0.62 | 5.98 ± 1.83 | 6.47 ± 2.45 |
| FPI (pmol/l) | 22.17 ± 11.72 | 111.86 ± 86.35 | 148.30 ± 110.35 |
| HbA1c (%) | 5.72 ± 0.48 | 6.05 ± 1.33 | 6.08 ± 1.16 |
| HOMA-Index | 0.77 ± 0.47 | 4.85 ± 4.24 | 6.07 ± 6.39 |
| Total cholesterol (mmol/l) | 5.01 ± 0.76 | 5.20 ± 1.81 | 4.85 ± 1.09 |
| HDL-cholesterol (mmol/l) | 1.21 ± 0.29 | 1.25 ± 0.30 | 1.17 ± 0.66 |
| LDL-cholesterol (mmol/l) | 2.97 ± 0.37 | 3.33 ± 1.03 | 3.07 ± 0.95 |
| Triglycerides (mmol/l) | 1.23 ± 0.50 | 1.86 ± 1.21 | 2.12 ± 2.42 |
| CrP (mg/L) | 8.76 ± 12.60 | 7.70 ± 15.54 | 13.16 ± 18.03 |
Data are given as means ± SD. AT, adipose tissue; BMI, body max index; CrP, C-reactive protein; FPG, fasting plasma glucose; FPI, fasting plasma insulin; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol; SAT, subcutaneous adipose tissue; VAT, visceral adipose tissue; WHR, waist to hip ratio.